Cytotoxicity of bovine seminal ribonuclease: monomer versus dimer.
Bovine seminal ribonuclease (BS-RNase) is a homologue of bovine pancreatic ribonuclease (RNase A). Unlike RNase A, BS-RNase has notable toxicity for human tumor cells. Wild-type BS-RNase is a homodimer linked by two intermolecular disulfide bonds. This quaternary structure endows BS-RNase with resistance to inhibition by the cytosolic ribonuclease inhibitor protein (RI), which binds tightly to RNase A and monomeric BS-RNase. Here, we report on the creation and analysis of monomeric variants of BS-RNase that evade RI but retain full enzymatic activity. The cytotoxic activity of these monomeric variants exceeds that of the wild-type dimer by up to 30-fold, indicating that the dimeric structure of BS-RNase is not required for cytotoxicity. Dimers of these monomeric variants are more cytotoxic than wild-type BS-RNase, suggesting that the cytotoxicity of the wild-type enzyme is limited by RI inhibition following dissociation of the dimer in the reducing environment of the cytosol. Finally, the cytotoxic activity of these dimers is less than that of the constituent monomers, indicating that their quaternary structure is a liability. These data provide new insight into structure-function relationships of BS-RNase. Moreover, BS-RNase monomers described herein are more toxic to human tumor cells than is any known variant or homologue of RNase A including Onconase, an amphibian homologue in phase III clinical trials for the treatment of unresectable malignant mesothelioma.
Lee
J Eugene
JE
Departments of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Raines
Ronald T
RT
D000595:Amino Acid Sequence; D000818:Animals; D002417:Cattle; D049109:Cell Proliferation / Q000187:drug effects*; D019281:Dimerization; D004791:Enzyme Inhibitors; D006801:Humans; D008297:Male; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010926:Placental Hormones / Q000494:pharmacology; D020836:Protein Structure, Quaternary; D012259:Ribonuclease, Pancreatic / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012260:Ribonucleases / Q000494:pharmacology / Q000633:toxicity*; D012661:Semen / Q000201:enzymology*; D016415:Sequence Alignment; D014407:Tumor Cells, Cultured / Q000187:drug effects
D004791:Enzyme Inhibitors; D010926:Placental Hormones; C022052:placental ribonuclease inhibitor; D012260:Ribonucleases; D012259:Ribonuclease, Pancreatic